These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9236105)

  • 21. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors.
    Seifert R; Wenzel-Seifert K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):381-416. PubMed ID: 12382069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus.
    Selley DE; Liu Q; Childers SR
    J Pharmacol Exp Ther; 1998 May; 285(2):496-505. PubMed ID: 9580589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A2A adenosine-receptor-mediated facilitation of noradrenaline release in rat tail artery involves protein kinase C activation and betagamma subunits formed after alpha2-adrenoceptor activation.
    Fresco P; Oliveira JM; Kunc F; Soares AS; Rocha-Pereira C; Gonçalves J; Diniz C
    Neurochem Int; 2007 Jul; 51(1):47-56. PubMed ID: 17493708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human 5-HT1 receptor subtypes exhibit distinct G protein coupling behaviors in membranes from Sf9 cells.
    Clawges HM; Depree KM; Parker EM; Graber SG
    Biochemistry; 1997 Oct; 36(42):12930-8. PubMed ID: 9335552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inverse agonist exposure enhances ligand binding and G protein activation of the human MT1 melatonin receptor, but leads to receptor down-regulation.
    Kokkola T; Vaittinen M; Laitinen JT
    J Pineal Res; 2007 Oct; 43(3):255-62. PubMed ID: 17803522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can a GDP-liganded G-protein be active?
    Wieland T; Michel MC
    Mol Pharmacol; 2005 Sep; 68(3):559-62. PubMed ID: 15980156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S111N mutation in the helical domain of human Gs(alpha) reduces its GDP/GTP exchange rate.
    Brito M; Guzmán L; Romo X; Soto X; Hinrichs MV; Olate J
    J Cell Biochem; 2002; 85(3):615-20. PubMed ID: 11968001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An aspartate residue at the extracellular boundary of TMII and an arginine residue in TMVII of the gastrin-releasing peptide receptor interact to facilitate heterotrimeric G protein coupling.
    Donohue PJ; Sainz E; Akeson M; Kroog GS; Mantey SA; Battey JF; Jensen RT; Northup JK
    Biochemistry; 1999 Jul; 38(29):9366-72. PubMed ID: 10413511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic hypotheses for the activation of G-protein-coupled receptors.
    Fong TM
    Cell Signal; 1996 Mar; 8(3):217-24. PubMed ID: 8736706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A kinetic model of GPCRs: analysis of G protein activity, occupancy, coupling and receptor-state affinity constants.
    Stein RS; Ehlert FJ
    J Recept Signal Transduct Res; 2015; 35(4):269-83. PubMed ID: 25353707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics versus equilibrium: the importance of GTP in GPCR activation.
    Waelbroeck I
    Trends Pharmacol Sci; 1999 Dec; 20(12):477-81. PubMed ID: 10603489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cubic ternary complex receptor-occupancy model. III. resurrecting efficacy.
    Weiss JM; Morgan PH; Lutz MW; Kenakin TP
    J Theor Biol; 1996 Aug; 181(4):381-97. PubMed ID: 8949584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. G-protein coupled receptors: conformations and states.
    Strange PG
    Biochem Pharmacol; 1999 Oct; 58(7):1081-8. PubMed ID: 10484065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The two-state model of receptor activation.
    Leff P
    Trends Pharmacol Sci; 1995 Mar; 16(3):89-97. PubMed ID: 7540781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of the molecular mechanism of G protein-coupled receptor activation on the process of signal transduction.
    Pardo L; Campillo M; Giraldo J
    Eur J Pharmacol; 1997 Sep; 335(1):73-87. PubMed ID: 9371548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha helix content of G protein alpha subunit is decreased upon activation by receptor mimetics.
    Tanaka T; Kohno T; Kinoshita S; Mukai H; Itoh H; Ohya M; Miyazawa T; Higashijima T; Wakamatsu K
    J Biol Chem; 1998 Feb; 273(6):3247-52. PubMed ID: 9452438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A three-state receptor model: predictions of multiple agonist pharmacology for the same receptor type.
    Scaramellini C; Leff P
    Ann N Y Acad Sci; 1998 Dec; 861():97-103. PubMed ID: 9928245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion-limited reactions in G-protein activation: unexpected consequences of antagonist and agonist competition.
    Brinkerhoff CJ; Choi JS; Linderman JJ
    J Theor Biol; 2008 Apr; 251(4):561-9. PubMed ID: 18289560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of a ternary model for the binding of agonists to neurohumoral receptors.
    Lee TW; Sole MJ; Wells JW
    Biochemistry; 1986 Nov; 25(22):7009-20. PubMed ID: 2879554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.